Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?

A Huttner, S Harbarth, WW Hope… - Journal of …, 2015 - academic.oup.com
Traditional antibiotic dosing was not designed for today's escalating antibiotic resistance,
lack of novel antibiotics and growing complexity in patient populations. Dosing that ensures …

Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review

E Castagnola, G Cangemi, A Mesini… - International journal of …, 2021 - Elsevier
Cystic fibrosis affects several organs, predisposing patients to severe bacterial respiratory
infections, including those caused by methicillin-resistant Staphylococcus aureus. Cystic …

Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung

KA Rodvold, WW Hope, SE Boyd - Current Opinion in Pharmacology, 2017 - Elsevier
Highlights•Bronchoalveolar lavage for determining epithelial lining fluid exposures of
antibiotics.•Discussion about conducting intrapulmonary pharmacokinetic studies in critically …

[HTML][HTML] Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults

T Welte, M Kantecki, GG Stone, J Hammond - International journal of …, 2019 - Elsevier
Abstract Staphylococcus aureus (S. aureus), including methicillin-resistant S. aureus
(MRSA), is an important aetiological cause of community-acquired pneumonia (CAP) and …

Nosocomial infections and ventilator-associated pneumonia in cancer patients

JV Divatia, JG Pulinilkunnathil, SN Myatra - Oncologic Critical Care, 2020 - Springer
Nosocomial infections or healthcare-acquired infections are a common cause of increased
morbidity and mortality among hospitalized patients. Cancer patients are at an increased …

[HTML][HTML] Why don't we have more inhaled antibiotics to treat ventilator-associated pneumonia?

DA Sweeney, AC Kalil - Clinical Microbiology and Infection, 2019 - Elsevier
Background The increasing prevalence of ventilator-associated pneumonia (VAP) due to
either multidrug-resistant (MDR) organisms or infections with limited treatment options (ie …

Pharmacodynamics of aerosolized fosfomycin and amikacin against resistant clinical isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a hollow …

FB Sime, A Johnson, S Whalley… - Antimicrobial agents …, 2017 - Am Soc Microbiol
There has been a resurgence of interest in aerosolization of antibiotics for treatment of
patients with severe pneumonia caused by multidrug-resistant pathogens. A combination …

Lung penetration and pneumococcal target binding of antibiotics in lower respiratory tract infection

PTN Nguyen, NV Le, HMN Dinh… - Current Medical …, 2022 - Taylor & Francis
Objectives To achieve the therapeutic effects, antibiotics must penetrate rapidly into infection
sites and bind to targets. This study reviewed updated knowledge on the ability of antibiotics …

Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated …

O Pajot, C Burdet, C Couffignal… - Journal of …, 2015 - academic.oup.com
Objectives Despite recent advances, antibiotic therapy of ventilator-associated pneumonia
(VAP) in ICU patients is still challenging. We assessed the impact of imipenem and amikacin …

Evaluasi Penggunaan Terapi Antibiotik Empiris Terhadap Luaran Klinis Pasien Pneumonia Komunitas Rawat Inap

SAB Pangeran, MA Manggau… - Majalah Farmasi dan …, 2022 - journal.unhas.ac.id
Pneumonia komunitas merupakan penyakit infeksi pada parenkim paru-paru yang
mengancam jiwa sehingga dapat diberikan terapi antibiotik empiris. Penelitian ini bertujuan …